Remove Big Data Remove Clinical Research Remove Engineer
article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

The webinar explored the potential of the technology to process the vast amount of data languishing untapped in EHRs, while ensuring that patient data privacy and safety is maintained at all times. Ignacio is in demand as an international speaker at digital health, clinical research, science and technology events and congresses.

Big Data 104
article thumbnail

June 26, 2023: NIMHD Director Discusses Ways Researchers Can Help Reduce Health Disparities

Rethinking Clinical Trials

Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD), shared his thoughts on national priorities for reducing health disparities and opportunities for clinical researchers to help promote health equity.

Research 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. A notable issue with clinical trials is the homogeneity of the patient database.

article thumbnail

Syntegra Partnering with National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation to Democratize Access to the Largest Set of COVID-19 Patient Records

The Pharma Data

18, 2021 /PRNewswire/ — Today Syntegra and the National Institutes of Health (NIH) have announced a collaboration to validate Syntegra’s AI-enabled synthetic data technology to advance the understanding of and care for COVID-19. rows of data. rows of data. . SAN FRANCISCO , Jan. .

article thumbnail

Massive Bio Launches Industry’s First NASA-Style, Oncology Clinical Trial Command Center to Disrupt and Accelerate Trial Enrollment, Featuring 72-Hour Instant Enrollment from Time of Patient Identification

The Pharma Data

Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations.

article thumbnail

Genmab’s Silver Anniversary: Reflecting on 25 Years of Breakthroughs in Antibody Therapeutics

XTalks

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.